Affymax and Takeda Announce Preliminary U.S. Registration Strategy for ... - MarketWatch (press release) PDF Print
MarketWatch (press release)Subject to feedback from the FDA, the plan is to pursue a New Drug Application (NDA) for treatment of anemia in dialysis patients, while continuing to

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.